Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
about
Current concepts and dilemmas in idiopathic interstitial pneumoniasImpact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumoniaBaseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumoniaAzithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center studyThe diagnosis of idiopathic pulmonary fibrosis: current and future approaches.Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study.Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosisComorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.Role of pirfenidone in the management of pulmonary fibrosis.The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis.Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis.Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis.A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.Acute Exacerbation in Interstitial Lung Disease.Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports.Recent advances in managing idiopathic pulmonary fibrosis.The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Recipient selection process and listing for lung transplantation.The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.Outcomes and mortality prediction model of critically ill adults with acute respiratory failure and interstitial lung disease.OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF.What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia.Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.Secondary spontaneous pneumothorax in idiopathic pulmonary fibrosis: Grim news.Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis.Idiopathic pulmonary fibrosis: A guide for nurse practitioners.Update in Interstitial Lung Disease 2016.Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis.
P2860
Q28074045-4DF25EC9-3183-4EA7-8DF5-9E2B2806A1DBQ30846353-8776311D-A13C-4033-9D7E-BFA334A1F7C3Q33632632-CC099437-59D4-4F0B-8E9F-38ED27BFAC00Q33814559-EADB561E-4648-4D1A-9DFA-A443F9D76F23Q33924950-6BC27C3F-4EF6-432A-A3AF-71FE7B32042DQ36222034-9E16B33A-B75C-44C5-A80E-FA9B21D8148BQ37237739-53FD3ABC-ABF2-407C-AC5B-178362EBEFA6Q37743018-4EF00DDD-03CD-48F4-BEE4-D89E104C5CB4Q38616538-19E0B21D-527C-46C8-9405-E9B71F97EC16Q38634828-D1EE1704-5CFA-4C38-B610-D9A65A294FCEQ38712044-614A43B4-E566-44BA-AB12-70DF41235B11Q38784085-74CF4CB8-6CB5-48D5-A3A8-6C2508B47DEBQ38804833-A4948BFC-E179-4B47-B9BC-E427787A5775Q39257627-6BB0F060-C22A-487C-92EA-9B8AB0DBF0B0Q39344375-AA42A535-E564-4BD0-98C1-241F672FEBF9Q40272697-AF361C7A-593A-4475-805C-96C22011CC5CQ41151927-849E7562-64EA-4EE1-B27A-EF7571A91FBFQ41384484-ED25CF81-E208-4B88-AFFF-FAA5A032BC56Q41429996-CEAA7718-FBBE-42A8-939B-D2F95D4F651CQ42325050-7A33FC00-9B67-4F8A-9804-EB9D3295BA18Q43179219-636138C6-E654-43C4-972B-C63E57FC889AQ46018904-990BE540-D43E-4C65-8B48-CD11AB9D1AEDQ46486721-5B7D9E4A-9964-4810-8A8C-FEC3588B5722Q47118064-033BE0F5-D46B-448D-BE33-870EB67FE767Q47157713-A5DCDDA9-66E1-457B-B5D1-0C96B21572F2Q47216049-0D906998-744F-4B0F-A306-FAFACD846EA3Q47221291-F8E60B2F-DC6F-459E-A7D6-35965E87B672Q47381476-939D4015-49DF-4D9C-B943-A6B176EB3B6AQ47608285-AB620FE5-E76A-4B30-A1FF-C467873F7E84Q47652119-C76FAA14-7C47-4B38-9FB5-BC93D8EBEF27Q47713338-2ABCE0F7-35A1-444A-9471-854EF2773008Q47715898-6288DF72-A652-4443-838B-14466A47E6CEQ47791471-DC0D781D-4E4D-41B7-B086-A44DE0FCFE9EQ47910684-4A88FB16-A209-406B-B0BB-312BA73D53A2Q48096354-39A0B8E8-46B0-4168-B702-DE7B036D5876Q48280829-703A925C-5D81-4334-B69F-B3EE175E2DC8Q48301589-DDF113B2-59E5-4BF6-9DFD-97E50C0B573CQ49712864-AC599252-D376-4044-AB83-4EAD4642BE9EQ49734357-6966E35E-CC4F-44D6-ADD4-EA55A53719DCQ52659380-E9EDA355-C79E-4A03-BE71-60775CCFD391
P2860
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Acute Exacerbation of Idiopath ...... national Working Group Report.
@en
type
label
Acute Exacerbation of Idiopath ...... national Working Group Report.
@en
prefLabel
Acute Exacerbation of Idiopath ...... national Working Group Report.
@en
P2093
P2860
P50
P1476
Acute Exacerbation of Idiopath ...... rnational Working Group Report
@en
P2093
Athol U Wells
Christopher J Ryerson
David A Lynch
David M Hansell
Dong Soon Kim
Fernando J Martinez
Ganesh Raghu
Harold R Collard
Hiroyuki Taniguchi
Jeffrey L Myers
P2860
P304
P356
10.1164/RCCM.201604-0801CI
P407
P577
2016-08-01T00:00:00Z